New Drug Combo for High-Risk Prostate Cancer: Xtandi and Leuprolide
In a new development for prostate cancer treatment, the FDA has approved the use of Xtandi (enzalutamide) in combination with leuprolide for patients with high-risk prostate cancer. This approval introduces […]
New Drug Combo for High-Risk Prostate Cancer: Xtandi and Leuprolide Read More »